Literature DB >> 14674849

Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine.

D M Eagle1, T W Robbins.   

Abstract

The stop-signal task measures the ability to inhibit a response that has already been initiated, that is, the ability to stop. Imaging studies have implicated frontostriatal circuitry in the mediation of this form of response control. The authors report inhibition functions of normal rats and those with medial striatal damage performing the stop-signal task. Excitotoxic lesions of the medial striatum produced significant deficits on task performance, including increased omissions on the go task and flattened inhibition function, possibly as a result of increased reaction-time mean and variability. Medial striatal lesions also significantly slowed stop-signal reaction time. Subsequent treatment with d-amphetamine removed (0.3 mg/kg) or exacerbated (1.0 mg/kg) this deficit. (c) 2003 APA

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674849     DOI: 10.1037/0735-7044.117.6.1302

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  105 in total

1.  A modified adjusting delay task to assess impulsive choice between isocaloric reinforcers in non-deprived male rats: effects of 5-HT₂A/C and 5-HT₁A receptor agonists.

Authors:  Angelo Blasio; Aditi R Narayan; Barbara J Kaminski; Luca Steardo; Valentina Sabino; Pietro Cottone
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

2.  Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans.

Authors:  Dara G Ghahremani; Buyean Lee; Chelsea L Robertson; Golnaz Tabibnia; Andrew T Morgan; Natalie De Shetler; Amira K Brown; John R Monterosso; Adam R Aron; Mark A Mandelkern; Russell A Poldrack; Edythe D London
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

3.  When response inhibition is followed by response reengagement: an event-related fMRI study.

Authors:  Maren Boecker; Barbara Drueke; Verena Vorhold; Andre Knops; Bernd Philippen; Siegfried Gauggel
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

4.  Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.

Authors:  Chelsea L Robertson; Kenji Ishibashi; Mark A Mandelkern; Amira K Brown; Dara G Ghahremani; Fred Sabb; Robert Bilder; Tyrone Cannon; Jacqueline Borg; Edythe D London
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

5.  Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization.

Authors:  Travis M Moschak; Katherine A Stang; Tamara J Phillips; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2012-02-04       Impact factor: 4.530

Review 6.  Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition.

Authors:  Adam R Aron; Sarah Durston; Dawn M Eagle; Gordon D Logan; Cathy M Stinear; Veit Stuphorn
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

7.  Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus.

Authors:  Adam R Aron; Russell A Poldrack
Journal:  J Neurosci       Date:  2006-03-01       Impact factor: 6.167

Review 8.  The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks.

Authors:  Dawn M Eagle; Andrea Bari; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2008-06-10       Impact factor: 4.530

9.  Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.

Authors:  Lori A Newman; Jenna Darling; Jill McGaughy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-22       Impact factor: 4.530

10.  Fronto-striatal functional connectivity during response inhibition in alcohol dependence.

Authors:  Kelly E Courtney; Dara G Ghahremani; Lara A Ray
Journal:  Addict Biol       Date:  2012-12-13       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.